Clinical Trials Browser

Withdrawn × INDUSTRY × Radiodermatitis × Clear all

NCT04692389 2022-02-08

Jalosome® Soothing Gel Efficacy Grade 2 or 3 Radiodermatitis.

Phase NA Withdrawn

Neoplasms, Pain, Radiodermatitis

NCT01544504 2012-05-28

Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy

Phase 1/2 Withdrawn

Radiodermatitis